Tuesday, May 6, 2025

LEOS (LASER ENDOSCOPY OPHTHALMIC SYSTEM)

 


BVI Medical, a leading global ophthalmic device company, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its innovative glaucoma surgical system, Leos™ (Laser Endoscopy Ophthalmic System).

Leos™ introduces a novel, more intuitive laser endoscopic cyclophotocoagulation (ECP) procedure that integrates seamlessly into the surgical workflow.

This laser system lowers intraocular pressure by addressing aqueous humor production in a minimally invasive ab interno procedure.

It incorporates unique endoscopic capabilities to provide superior visualization of the eye anatomy in a way not seen in the past, or with the latest imaging systems.

https://www.bvimedical.com/bvi-medical-announces-approval-of-breakthrough-technology-fda-510k-clearance-of-its-laser-endoscopy-ophthalmic-system-leos/




at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

RETINITIS PIGMENTOSA AND GLAUCOMA

Retinitis pigmentosa (RP) is a rare inherited retinal disorder, characterized by night-blindness and ultimately loss of vision due to involv...

  • (no title)
    PEARLS FOR CORRECT ASSESSMENT OF THE OPTIC DISC Based on the article by  PROF. BURAK TURGUT and available at the following link: htt...
  • (no title)
    PARAPAPILLARY ATROPHY The Optic Nerve Head (ONH) is often surrounded by different zones of atrophic-like changes occurring in th...
  • (no title)
    AQUEOUS OUTFLOW PATHWAYS Aqueous humor (AH) is produced by the non-pigmented epithelium of the ciliary body. It flows into the post...